UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

The New England journal of medicine, 2010-04, Vol.362 (15), p.1383-1395

2010

Volltextzugriff (PDF)

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Gastroenterology (New York, N.Y. 1943), 2007-10, Vol.133 (4), p.1099-1105

2007

Volltextzugriff (PDF)

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

The American journal of gastroenterology, 2006-10, Vol.101 (10), p.2218-2222

2006

Volltextzugriff (PDF)

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

The American journal of gastroenterology, 2008-05, Vol.103 (5), p.1203-1209

2008

Volltextzugriff (PDF)

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

The New England journal of medicine, 1994-06, Vol.330 (26), p.1841-1845

1994

Volltextzugriff (PDF)

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

The American journal of gastroenterology, 2006-07, Vol.101 (7), p.1546-1550

2006

Volltextzugriff (PDF)

Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference

Inflammatory bowel diseases, 1998-11, Vol.4 (4), p.328-329

Kornbluth, A

1998

Volltextzugriff (PDF)

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1779-1785

2020

Volltextzugriff (PDF)

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Gut, 2014-01, Vol.63 (1), p.88-95

2014

Volltextzugriff (PDF)

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.599-604

2011

Volltextzugriff (PDF)

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.978-986.e5

2013

Volltextzugriff (PDF)

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Clinical gastroenterology and hepatology, 2008-10, Vol.6 (10), p.1112-1116

2008

Volltextzugriff (PDF)

Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease

Clinical gastroenterology and hepatology, 2015-03, Vol.13 (3), p.539-547.e2

2015

Volltextzugriff (PDF)

Adjustable Intragastric Balloons: A 12-Month Pilot Trial in Endoscopic Weight Loss Management

Obesity surgery, 2011-10, Vol.21 (10), p.1499-1507

2011

Volltextzugriff (PDF)

Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine

Clinical gastroenterology and hepatology, 2008-11, Vol.6 (11), p.1225-1230

2008

Volltextzugriff (PDF)

Delayed-Release Oral Mesalamine at 4.8 g day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial

The American journal of gastroenterology, 2005-11, Vol.100 (11), p.2478-2485

2005

Volltextzugriff (PDF)

Clinical presentation and outcomes of inflammatory bowel disease patients admitted to the intensive care unit

Journal of clinical gastroenterology, 2013-07, Vol.47 (6), p.485-490

2013

Volltextzugriff (PDF)

Teduglutide, a novel mucosally active analog of glucagon‐like peptide‐2 (GLP‐2) for the treatment of moderate to severe Crohn's disease

Inflammatory bowel diseases, 2010-06, Vol.16 (6), p.962-973

2010

Volltextzugriff (PDF)

Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC

Inflammatory bowel diseases, 2015-03, Vol.21 (3), p.606-614

2015

Volltextzugriff (PDF)

Adverse Events Associated With the Use of Cyclosporine in Patients With Inflammatory Bowel Disease

The American journal of gastroenterology, 2008-04, Vol.103 (4), p.937-943

2008

Volltextzugriff (PDF)

Does hormonal therapy have any benefit for bleeding angiodysplasia?

Journal of clinical gastroenterology, 1992-09, Vol.15 (2), p.99-103

1992

Volltextzugriff (PDF)

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

Gut, 2010-06, Vol.59 (6), p.760-766

2010

Volltextzugriff (PDF)

The MMAS-8, a screening tool for determining nonadherent behavior, should not be dismissed in IBD

The American journal of gastroenterology, 2012-06, Vol.107 (6), p.951-952

2012

Volltextzugriff (PDF)

Treatment responses in collagenous colitis

The American journal of gastroenterology, 2001-03, Vol.96 (3), p.818-821

2001

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Humans
(32)
Life Sciences & Biomedicine
(30)
Male
(30)
Science & Technology
(30)
Adult
(27)
Gastroenterology & Hepatology
(26)
Middle Aged
(19)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Aged
(11)
Treatment Outcome
(11)
Crohn Disease - Drug Therapy
(10)
Gastroenterology
(10)
Gastroenterology. Liver. Pancreas. Abdomen
(9)
Other Diseases. Semiology
(9)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(9)
Adolescent
(8)
Antibodies, Monoclonal - Therapeutic Use
(8)
Infliximab
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease

Adjustable Intragastric Balloons: A 12-Month Pilot Trial in Endoscopic Weight Loss Management

Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine

Delayed-Release Oral Mesalamine at 4.8 g day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial

Clinical presentation and outcomes of inflammatory bowel disease patients admitted to the intensive care unit

Teduglutide, a novel mucosally active analog of glucagon‐like peptide‐2 (GLP‐2) for the treatment of moderate to severe Crohn's disease

Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC

Adverse Events Associated With the Use of Cyclosporine in Patients With Inflammatory Bowel Disease

Does hormonal therapy have any benefit for bleeding angiodysplasia?

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

The MMAS-8, a screening tool for determining nonadherent behavior, should not be dismissed in IBD

Treatment responses in collagenous colitis

Aktive Filter

Suchergebnisse filtern